These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 33119251)
1. Can Neurotropic Free-Living Amoeba Serve as a Model to Study SARS-CoV-2 Pathogenesis? Baig AM ACS Chem Neurosci; 2020 Nov; 11(22):3697-3700. PubMed ID: 33119251 [TBL] [Abstract][Full Text] [Related]
2. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart. Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018 [TBL] [Abstract][Full Text] [Related]
3. Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2). Guo X; Chen Z; Xia Y; Lin W; Li H J Transl Med; 2020 Aug; 18(1):321. PubMed ID: 32831104 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients. Dai YJ; Zhang WN; Wang WD; He SY; Liang CC; Wang DW Int J Biol Sci; 2020; 16(15):3028-3036. PubMed ID: 33061814 [TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC. Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V Elife; 2020 May; 9():. PubMed ID: 32452762 [TBL] [Abstract][Full Text] [Related]
6. Expression Pattern of the SARS-CoV-2 Entry Genes Liu Y; Qu HQ; Qu J; Tian L; Hakonarson H Viruses; 2020 Oct; 12(10):. PubMed ID: 33081421 [TBL] [Abstract][Full Text] [Related]
7. Sex-mediated effects of ACE2 and TMPRSS2 on the incidence and severity of COVID-19; The need for genetic implementation. Alshahawey M; Raslan M; Sabri N Curr Res Transl Med; 2020 Nov; 68(4):149-150. PubMed ID: 32917573 [No Abstract] [Full Text] [Related]
8. Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals. Hayashi T; Abiko K; Mandai M; Yaegashi N; Konishi I Vet Q; 2020 Dec; 40(1):243-249. PubMed ID: 32921279 [TBL] [Abstract][Full Text] [Related]
9. Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity. Sakaguchi W; Kubota N; Shimizu T; Saruta J; Fuchida S; Kawata A; Yamamoto Y; Sugimoto M; Yakeishi M; Tsukinoki K Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825469 [TBL] [Abstract][Full Text] [Related]
10. Alternative splicing of ACE2 possibly generates variants that may limit the entry of SARS-CoV-2: a potential therapeutic approach using SSOs. Rehman SU; Tabish M Clin Sci (Lond); 2020 May; 134(10):1143-1150. PubMed ID: 32442315 [TBL] [Abstract][Full Text] [Related]
11. Molecular identification of Acanthamoeba spp., Balamuthia mandrillaris and Naegleria fowleri in soil samples using quantitative real-time PCR assay in Turkey; Hidden danger in the soil! Aykur M; Dagci H Acta Trop; 2023 Aug; 244():106956. PubMed ID: 37244403 [TBL] [Abstract][Full Text] [Related]
12. Co-Expression of Mitochondrial Genes and ACE2 in Cornea Involved in COVID-19. Yuan J; Fan D; Xue Z; Qu J; Su J Invest Ophthalmol Vis Sci; 2020 Oct; 61(12):13. PubMed ID: 33049061 [TBL] [Abstract][Full Text] [Related]
13. Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)? Lippi G; Lavie CJ; Henry BM; Sanchis-Gomar F Clin Chem Lab Med; 2020 Aug; 58(9):1415-1422. PubMed ID: 32598305 [TBL] [Abstract][Full Text] [Related]
14. A suspicious role of interferon in the pathogenesis of SARS-CoV-2 by enhancing expression of ACE2. Su S; Jiang S Signal Transduct Target Ther; 2020 May; 5(1):71. PubMed ID: 32435059 [No Abstract] [Full Text] [Related]
15. The big challenge of SARS-CoV-2 latency: testes as reservoir. López-Romero R; Nambo-Lucio MJ; Salcedo-Carrillo E; Hernández-Cueto MLÁ; Salcedo-Vargas M Gac Med Mex; 2020; 156(4):328-333. PubMed ID: 32831326 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection. Kong Q; Xiang Z; Wu Y; Gu Y; Guo J; Geng F Mol Cancer; 2020 Apr; 19(1):80. PubMed ID: 32345328 [TBL] [Abstract][Full Text] [Related]
17. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein. Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194 [TBL] [Abstract][Full Text] [Related]
18. Cutaneous susceptibility to SARS-CoV-2 infection according to the expression of viral entry factors in the skin. Garduño-Soto M; Choreño-Parra JA Gac Med Mex; 2020; 156(4):354-357. PubMed ID: 32831324 [TBL] [Abstract][Full Text] [Related]
19. [Are there genetic variants that can modify the course of the COVID-19 pandemic?]. Azurmendi PJ Medicina (B Aires); 2020; 80 Suppl 3():79-81. PubMed ID: 32658852 [No Abstract] [Full Text] [Related]
20. SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis. Xu J; Xu X; Jiang L; Dua K; Hansbro PM; Liu G Respir Res; 2020 Jul; 21(1):182. PubMed ID: 32664949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]